tradingkey.logo

Metagenomi Inc

MGX

2.300USD

+0.050+2.22%
Cierre 08/04, 16:00ETCotizaciones retrasadas 15 min
85.98MCap. mercado
PérdidaP/E TTM

Metagenomi Inc

2.300

+0.050+2.22%
Más Datos de Metagenomi Inc Compañía
Metagenomi, Inc. is a precision genetic medicine company. The Company is focused on developing curative therapeutics for patients using its comprehensive metagenomics derived toolbox. Its diverse and modular genome editing toolbox is designed to precisely target any site in the human genome. Its comprehensive genome editing toolbox includes programmable nucleases, base editors, and RNA and DNA-mediated integration systems, including prime editing systems and clustered regularly interspaced short palindromic repeat (CRISPR)-associated transposases (CASTs). It has also developed an expansive and modular toolbox of genome editing systems that will allow it to interact with the human genome in a site-specific manner, where each tool can be matched to specific disease targets. Its platform enables it to rapidly and effectively find, screen, and select tools with the highest targetability, specificity, and efficiency in order to develop them into genetic medicine.
Información de la empresa
Símbolo de cotizaciónMGX
Nombre de la empresaMetagenomi Inc
Fecha de salida a bolsaFeb 09, 2024
Director ejecutivoDr. Brian C. Thomas, Ph.D.
Número de empleados202
Tipo de seguridadOrdinary Share
Fin del año fiscalFeb 09
Dirección5959 Horton St
CiudadEMERYVILLE
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal94608
Teléfono15108714880
Sitio Webhttps://metagenomi.co/
Símbolo de cotizaciónMGX
Fecha de salida a bolsaFeb 09, 2024
Director ejecutivoDr. Brian C. Thomas, Ph.D.
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Brian C. Thomas, Ph.D.
Dr. Brian C. Thomas, Ph.D.
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
2.37M
-0.45%
Dr. Jian Irish, Ph.D.
Dr. Jian Irish, Ph.D.
President, Chief Operating Officer, Director
President, Chief Operating Officer, Director
579.04K
-1.09%
Dr. Sarah B. Noonberg, M.D., Ph.D.
Dr. Sarah B. Noonberg, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
109.14K
-4.58%
,
,
Senior Vice President, Head of Legal, Compliance Officer and Corporate Secretary
Senior Vice President, Head of Legal, Compliance Officer and Corporate Secretary
--
--
Dr. Juergen Eckhardt, M.D.
Dr. Juergen Eckhardt, M.D.
Independent Director
Independent Director
--
--
Ms. Pamela M. (Pam) Wapnick
Ms. Pamela M. (Pam) Wapnick
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Eric H. Bjerkholt
Mr. Eric H. Bjerkholt
Independent Director
Independent Director
--
--
Dr. Willard H. Dere, M.D.
Dr. Willard H. Dere, M.D.
Lead Independent Director
Lead Independent Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Brian C. Thomas, Ph.D.
Dr. Brian C. Thomas, Ph.D.
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
2.37M
-0.45%
Dr. Jian Irish, Ph.D.
Dr. Jian Irish, Ph.D.
President, Chief Operating Officer, Director
President, Chief Operating Officer, Director
579.04K
-1.09%
Dr. Sarah B. Noonberg, M.D., Ph.D.
Dr. Sarah B. Noonberg, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
109.14K
-4.58%
,
,
Senior Vice President, Head of Legal, Compliance Officer and Corporate Secretary
Senior Vice President, Head of Legal, Compliance Officer and Corporate Secretary
--
--
Dr. Juergen Eckhardt, M.D.
Dr. Juergen Eckhardt, M.D.
Independent Director
Independent Director
--
--
Ms. Pamela M. (Pam) Wapnick
Ms. Pamela M. (Pam) Wapnick
Chief Financial Officer
Chief Financial Officer
--
--
Desglose de ingresos
Sin datos
Sin datos
Por negocio
Por región
Sin datos
Estadísticas de accionistas
Actualizado: sáb., 17 de may
Actualizado: sáb., 17 de may
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Bayer HealthCare LLC
10.84%
Thomas (Brian C)
6.33%
Humboldt Capital, LLC
5.07%
The Vanguard Group, Inc.
3.90%
BlackRock Institutional Trust Company, N.A.
3.78%
Other
70.08%
Accionistas
Accionistas
Proporción
Bayer HealthCare LLC
10.84%
Thomas (Brian C)
6.33%
Humboldt Capital, LLC
5.07%
The Vanguard Group, Inc.
3.90%
BlackRock Institutional Trust Company, N.A.
3.78%
Other
70.08%
Tipos de accionistas
Accionistas
Proporción
Corporation
15.91%
Individual Investor
12.29%
Investment Advisor
11.49%
Investment Advisor/Hedge Fund
5.46%
Hedge Fund
4.68%
Venture Capital
2.97%
Sovereign Wealth Fund
0.96%
Research Firm
0.78%
Bank and Trust
0.08%
Other
45.38%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
158
20.59M
55.08%
-7.29M
2025Q1
157
20.44M
54.67%
-7.64M
2024Q4
143
21.51M
57.48%
-2.78M
2024Q3
116
23.74M
63.40%
-1.13M
2024Q2
94
26.05M
69.54%
+4.67M
2024Q1
65
26.68M
71.20%
+16.22M
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Bayer HealthCare LLC
4.05M
10.84%
--
--
Sep 30, 2024
Thomas (Brian C)
2.37M
6.33%
-10.79K
-0.45%
Jun 06, 2025
Humboldt Capital, LLC
1.90M
5.07%
--
--
Apr 14, 2025
The Vanguard Group, Inc.
1.46M
3.9%
+188.80K
+14.88%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
1.41M
3.78%
+62.14K
+4.59%
Mar 31, 2025
Bernales (Sebastian Ph.D.)
1.17M
3.14%
--
--
Apr 14, 2025
PFM Health Sciences, LP
885.80K
2.37%
--
--
Mar 31, 2025
Geode Capital Management, L.L.C.
619.57K
1.66%
+32.15K
+5.47%
Mar 31, 2025
Sozo Ventures LLC
581.58K
1.56%
--
--
Mar 31, 2025
Irish (Jian)
579.04K
1.55%
-6.39K
-1.09%
Jun 06, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 2 de ago
Actualizado: sáb., 2 de ago
Nombre
Proporción
iShares Micro-Cap ETF
0.01%
iShares Russell 2000 Value ETF
0%
Proshares Ultra Russell 2000
0%
ProShares Hedge Replication ETF
0%
Global X Russell 2000 ETF
0%
Schwab U.S. Small-Cap ETF
0%
iShares Russell 2000 ETF
0%
ProShares UltraPro Russell2000
0%
iShares Russell 2000 Growth ETF
0%
iShares Micro-Cap ETF
Proporción0.01%
iShares Russell 2000 Value ETF
Proporción0%
Proshares Ultra Russell 2000
Proporción0%
ProShares Hedge Replication ETF
Proporción0%
Global X Russell 2000 ETF
Proporción0%
Schwab U.S. Small-Cap ETF
Proporción0%
iShares Russell 2000 ETF
Proporción0%
ProShares UltraPro Russell2000
Proporción0%
iShares Russell 2000 Growth ETF
Proporción0%
Dividendos
Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
KeyAI